Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2005
06/29/2005EP1548121A1 Novel physiologically active substances
06/29/2005EP1548033A2 Higly branched soluble glucose polymers
06/29/2005EP1548032A1 Kdr peptides and vaccines comprising the same
06/29/2005EP1548024A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/29/2005EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same
06/29/2005EP1547614A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
06/29/2005EP1547608A1 Remedy
06/29/2005EP1547600A1 Female hormone-containing patch
06/29/2005EP1547598A1 NOVEL USES OF PROSTAGLANDIN D sb 2 /sb , PROSTAGLANDIN D sb 2 /sb AGONIST AND PROSTAGLANDIN D sb 2 /sb ANTAGONIST
06/29/2005EP1547584A1 Particulate product comprising pantethine
06/29/2005EP1546732A2 Modulation of the synthesis of insulin
06/29/2005EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
06/29/2005EP1546305A2 Implantable artificial organ devices
06/29/2005EP1546133A2 N-substitute-2-oxodihydropyridine derivatives as npy antagonists
06/29/2005EP1546111A2 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
06/29/2005EP1546105A1 Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546098A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546084A1 2,4-dihydroxybenzoic acid derivatives
06/29/2005EP1546083A1 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them
06/29/2005EP1545589A1 A method of modulating endothelial cell activity
06/29/2005EP1545562A1 Branched alpha-glucans for weight management
06/29/2005EP1545554A1 Methods and compositions for treating diabetes mellitis
06/29/2005EP1545552A1 Combination therapy wherein a serotonin reuptake inhibitor is used
06/29/2005EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
06/29/2005EP1545484A1 Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
06/29/2005EP1545460A2 Insulin molecule having protracted time action
06/29/2005EP1315727B1 7-oxo pyridopyrimidines
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
06/29/2005EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha
06/29/2005EP0735888B1 Purine compositions
06/29/2005CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same
06/29/2005CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof
06/29/2005CN1633436A Pyrrolopyrimidine derivatives
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633432A Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633421A Oxazole/thiazol-derivatives activators of the hppar-alpha receptor
06/29/2005CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/29/2005CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives
06/29/2005CN1633304A Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/29/2005CN1633302A Method for producing high-quality hydrophobic licorice extract
06/29/2005CN1633300A Percutaneous preparations
06/29/2005CN1633299A Estrogen replacement therapy
06/29/2005CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
06/29/2005CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
06/29/2005CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
06/29/2005CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
06/29/2005CN1633245A Water-dispersible coenzyme q10 dry powders
06/29/2005CN1632109A Highly expressed recombinant gutted adenovirus containing human constant region whole antibody gene and its use
06/29/2005CN1631866A Branched chain fatty acid for treating diabetes mellitus
06/29/2005CN1631431A Method for extracting ganoderma lucidum spore fat soluble active substance and its specified instrument for preparation
06/29/2005CN1631423A Chinese medicinal powder for treating diabetes and its production method
06/29/2005CN1631419A Phacellanthus extractive, its preparation and medical application
06/29/2005CN1631405A Externally applied quick acting formulation for weight reduction and its preparation method
06/29/2005CN1631379A Pharmaceutical composition and its preparing method and usage
06/29/2005CN1631376A Compound medicine compatibility method of ion pair agent and vanadium compound and the application thereof
06/29/2005CN1631375A Novel compound calcium replenishing tablet
06/29/2005CN1631374A Safety compound biologic calcium formulation
06/29/2005CN1631366A Enteric coated sustained releasing tablet of gliclazide óÄ and its preparation process
06/29/2005CN1631359A Compound calcium replenishing injection
06/29/2005CN1631198A Soya bean lecithin oral liquid
06/29/2005CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives
06/29/2005CN1208335C Thiazolidinedione derivative and its use as antidiabetic
06/29/2005CN1208333C Indole derivatives useful for the treatment of osteoporosis
06/29/2005CN1208329C Aniline derivatives
06/29/2005CN1208323C Alpha-substituted carboxylic acid derivatives
06/29/2005CN1208322C Dihydroindole and tetrahydroquinoline derivatives
06/29/2005CN1208083C Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder
06/29/2005CN1208066C Use of cyclic ether for preparation of medicaments affecting glucose tolerance
06/29/2005CN1208055C Use of amino acids for making medicine for treating to insulin-resistance
06/28/2005US6911545 Crystals of glucokinase and methods of growing them
06/28/2005US6911479 Side effect reduction; purity; removal of stereoisomers
06/28/2005US6911474 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
06/28/2005US6911468 Useful as a prophylactic or therapeutic agent for diabetes or the like
06/28/2005US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005US6911459 Pharmaceutical composition
06/28/2005US6911457 Diabetes imaging probes
06/28/2005US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists
06/28/2005US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents
06/28/2005US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4
06/28/2005US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
06/28/2005US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005US6911429 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
06/28/2005US6911426 Inhibitor of apoptosis proteins (IAP); survivin
06/28/2005US6911425 Integrin binding motif containing peptides and methods of treating skeletal diseases
06/28/2005US6911324 Induction of beta cell differentiation in human cells
06/28/2005US6911213 Pernasally absorbable insulin preparations
06/28/2005US6911211 Pharmaceutical and cosmetic carrier or composition for topical application
06/28/2005CA2146775C Novel vitamin d analogues
06/24/2005CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use
06/23/2005WO2005056784A1 Insulin-inducible polypeptide
1 ... 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 ... 1298